Papers - YOKOYAMA Yoshihito
-
Carcinosarcima of the fallopian tube: Report of four cases and review of literature
Yokoyama Y, Yokota M, Futagami M, Mizunuma H.
Asia-Pacific Journal of Clinical Oncology 8 303 - 311 2012.9
-
Is omentectomy mandatory in the operation for ovarian cancer? Preliminary results in a rat study
Yoshihito Yokoyama, Hachidai Hirakawa, Hui Wang, Hideki Mizunuma
European Journal of Obstetrics & Gynecology and Reproductive Biology 162 89 - 92 2012.8
-
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, Shih IM.
International Journal of Gynecological Cancer 22 1310 - 1315 2012.8
-
Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance.
Murakami A, Yakabe K, Yoshidomi K, Sueoka K, Nawata S, Yokoyama Y, Tsuchida S, Al-Mulla F, Sugino N.
Cancer Letters 323 69 - 76 2012.7
-
A case of ovarian mucinous adenocarcinoma in a premenarcheal girl.
Matsushita Y, Yokoyama Y, Taniguchi R, Abe K, Watanabe J, Mizunuma H.
International Journal of Clinical Oncology 17 517 - 521 2012.5
-
Malignant ovarian tumors with induced expression of carbonyl reductase show spontaneous regression.
Wang H, Yokoyama Y, Tsuchida S, Mizunuma H.
Clinical Medicine Insights: Oncology 6 107 - 115 2012.4
-
Efficacy of neoadjuvant chemotherapy followed by radical hysterectomy in locally advanced non-squamous carcinoma of the uterine cervix: a retrospective multicenter study of Tohoku Gynecologic Cancer Unit.
Shoji T, Kumagai S, Yoshizaki A, Yokoyama Y, Fujimoto T, Takano T, Yaegashi N, Nakahara K, Nishiyama H, Sugiyama T.
European Journal of Gynaecological Oncology 28 353 - 357 2012.4
-
Presentation of two patients with malignant granulosa cell tumors, with a review of the literature.
Tamura R, Yokoyama Y, Yanagita T, Matsumura Y, Abe K, Taniguchi R, Mizunuma H
World Journal of Surgical Oncology 10 185 2012.4
-
成熟嚢胞奇形種の悪性転化は術前に予測可能か？
二神真行、横山良仁、水沼英樹、水上浩哉
青森県臨床産婦人科医会誌 26 ( 2 ) 857 - 860 2012.3
-
希有な経過を辿った顆粒膜細胞腫の１例
柳田毅、田村良介、谷口綾亮、横山良仁、水沼英樹
青森県臨床産婦人科医会誌 26 ( 2 ) 66 - 71 2012.3
-
Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
Yokoyama Y, Xin B, Shigeto T, Mizunuma H.
Journal of Cancer Research and Clinical Oncology 137 1219 - 1228 2011.8
-
Irinotecan HydrochlorideとCisplatin併用療法が著効し完全切除が可能となった進行卵巣明細胞腺癌の1例
平川八大、二神真行、横山良仁、袴田健一、水沼英樹
癌と化学療法 38 857 - 860 2011.8
-
Suppression of carbonyl reductase expression enhances malignant behavior in uterine cervical squamous cell carcinoma: Carbonyl reductase predicts prognosis and lymph node metastasis.
Murakami A, Fukushima C, Yoshidomi K, Sueoka K, Nawata S, Yokoyama Y, Tsuchida S, Ismail E, Al-Mulla F, Sugino N.
Cancer Letters 311 77 - 84 2011.5
-
A case of uterine leiomyoma with intravenous leiomyomatosis – histological investigation of the pathological condition-(共著)
Fukuyama A, Yokoyama Y, Futagami M, Shigeto T, Wada R, Mizunuma H.
Pathology Oncology Research 17 171 - 174 2011.4
-
Phase II clinical study of the combination chemotherapy regimen of irinotecam plus oral etoposide for the treatment of recurrent ovarian cancer (TGCU 101 Group study).共著
Shoji T, Takatori E, Omi H, Kumagai S, Yoshizaki A, Yokoyama Y, Mizunuma H, Fujimoto T, Takano T, Yaegashi N, Tase T, Nakahara K, Kurachi H, Nishiyama H, Sugiyama T.
International Journal of Gynecological Cancer 21 44 - 50 2011.4
-
初経前の女児に発症した卵巣粘液性腺癌の一例
松下容子、横山良仁他
青森県臨床産婦人科医会誌 25 ( 2 ) 125 - 130 2011.3
-
子宮体癌の新臨床進行期分類は予後を正確に反映するか？
横山良仁、水沼英樹
青森県臨床産婦人科医会誌 25 ( 2 ) 73 - 77 2011.3
-
Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion.
Futagami M, Yokoyama Y, Mizunuma H.
European Journal of Gynaecological Oncology 32 ( 1 ) 99 - 102 2011.2
-
Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico—pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T, Nakahara K, Shoji T, Sugiyama T, Takano T, Yaegashi N, Yokoyama Y, Mizunuma H, Tase R, Satou H, Tanaka T, Motoyama T, Kurachi H.
Tohoku J Exp Med 223 91 - 96 2011.1
-
Peroxisome proliferator-activated receptor and epithelial ovarian cancer.
Yokoyama Y, Mizunuma H.
European Journal of Gynaecological Oncology 31 ( 6 ) 612 - 615 2010.12